Abstract:Background Emerging evidence has proven that long noncoding RNAs (lncRNAs) play important roles in human colorectal cancer (CRC) biology, while few lncRNAs have been characterised in CRC. Therefore, the functional significance of lncRNAs in the malignant progression of CRC still needs to be further explored. Methods By utilising publicly available lncRNAs expression profiling data and other publicly available lncRNAs expression profiling data, we screened out LINC00460, whose expression is significantly increased in CRC. The quantitative reverse transcriptase PCR (qRT-PCR) was used to analyse the expression of LINC00460 in 60 CRC tissues and correspond adjacent normal tissues and four CRC cell lines. Gain and loss of function approaches were used to investigate the biological role of LINC00460 both in vitro and in vivo. Bioinformatics analysis followed by qRT-PCR was performed to identify the putative targets of LINC00460, which were further verified by RNA immunoprecipitation (RIP), Chromatin immunoprecipitation (ChIP), Luciferase reporter assays, rescue experiments and western blotting assays. Results We found a novel lncRNA, LINC00460, whose expression was significantly over-expressed in all three publicly available microarray data. Consistently, qRT-PCR results also verified that LINC00460 was over-expressed in CRC tissues and cells. Furthermore, high LINC00460 expression levels in CRC specimens were correlated with larger tumour size, advanced tumour stage, lymph node metastasis and shorter overall survival. In vitro and in vivo assays of LINC00460 alterations revealed a complexly integrated phenotype affecting cell growth and apoptosis. Mechanistically, LINC00460 repressed kruppel like factor 2 (KLF2) transcription by binding to the enhancer of zeste homolog 2 (EZH2). LINC00460 also functioned as a molecular sponge for miR-149–5 p, antagonising its ability to repress cullin 4A (CUL4A) protein translation. Conclusions Taken together, our findings support a model in which the LINC00460/EZH2/KLF2 and LINC00460/miR-149–5 p/CUL4A crosstalk serve as critical effectors in CRC tumorigenesis and progression, suggesting new therapeutic directions in colorectal cancer.

KLF15 transcriptionally activates LINC00689 to inhibit colorectal cancer development

Abstract 991: Long Non-Coding RNA LINC01133 Inhibits Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer by Interacting with SRSF6

Long noncoding RNA LINC01550 inhibits colorectal cancer malignancy by suppressing the Wnt/β-catenin signaling pathway

A Positive Feedback Loop of Long Noncoding RNA LINC00152 and KLF5 Facilitates Breast Cancer Growth

Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression

IDDF2018-ABS-0125 Overexpression of LNCRNA LINC00460 Affects Cell Proliferation and Apoptosis by Regulating KLF2 and CUL4A Expression in Colorectal Cancer

A Novel Lncrna, LINC00460, Affects Cell Proliferation and Apoptosis by Regulating KLF2 and CUL4A Expression in Colorectal Cancer

Long Noncoding RNA LINC01594 Inhibits the CELF6-mediated Splicing of Oncogenic CD44 Variants to Promote Colorectal Cancer Metastasis

LncRNA KCNK15-AS1 inhibits pancreatic cancer progression by promoting the expression of its binding protein ACTR3B

LINC01134 Directly Binds and Regulates SLC1A5 Stability to Promotes Colorectal Cancer Progression

Long Noncoding RNA LINC01296 Plays an Oncogenic Role in Colorectal Cancer by Suppressing P15 Expression

The Long Noncoding RNA LINC00341 Suppresses Colorectal Carcinoma by Preventing Cell Migration and Apoptosis

LINC00265 Promotes Colorectal Tumorigenesis Via ZMIZ2 and USP7-mediated Stabilization of Β-Catenin

Upregulated Expression of Long Non-Coding RNA, LINC00460, Suppresses Proliferation of Colorectal Cancer

LINC00857 promotes cell proliferation and migration in colorectal cancer by interacting with YTHDC1 and stabilizing SLC7A5

Long noncoding RNA LINC00239 inhibits ferroptosis in colorectal cancer by binding to Keap1 to stabilize Nrf2

Up-regulation of LINC00467 Promotes the Tumourigenesis in Colorectal Cancer.

LINC00365 promotes colorectal cancer cell progression through the Wnt/β‐catenin signaling pathway

Long Non-coding RNA LINC00115 Contributes to the Progression of Colorectal Cancer by Targeting miR-489-3p via the PI3K/AKT/mTOR Pathway

Long Non-Coding RNA LINC00959 Predicts Colorectal Cancer Patient Prognosis and Inhibits Tumor Progression.

LINC00689 participates in proliferation, chemoresistance and metastasis via miR-31-5p/YAP/β-catenin axis in colorectal cancer